Benefits investigations are conducted to determine whether a therapy is covered under a patient's insurance, if a prior authorization is required, and which specialty pharmacies are preferred.
Some brands offer a field reimbursement manager who will work with your clinical staff and preferred pharmacy to help make sure patients don't fall through the cracks.
Reduce patient OOP costs for drug (and occasionally for drug administration/infusion costs or drug-related test costs)
Patient benefit
A portion (or all) of patient OOP (deductible, copay), typically up to monthly and/or annual max
Patient eligibility
Patient must enroll or activate (may permit HCPs to enroll on patient’s behalf for HCP-administered drugs)
Generally, must have commercial insurance (rarely, may permit uninsured patients to use)
May never be used with government insurance
How to sign up
Cards may be downloadable digital cards or hard copies
Some pharmacos offer debit cards with pre-loaded copay benefit
Typically, available through multiple channels (e.g., rep to HCP to patient; pharmacy to patient; patient via website, Hub live agent, or copay vendor (live agent or IVR); patient and HCP via Hub enrollment form)
Some HCP-administered product programs permit HCPs to enroll on a patient’s behalf through via Hub form
ASK PATIENT TO: Open Camera on Phone Scan QR Code & Tap Link
Learn More
Other resources brands publish to help support patients and caregivers.
Other resources
Learn More
Other resources brands publish to help support patients.
people also ask
Orkambi FAQs
How is the dosage of Orkambi?ORKAMBI is available in 5 dosages, including 125-100 mg Granules, 125-100 mg Tab, 125-200 mg Tab, 188-150 mg Granules and 94-75 mg Granules
What does Orkambi treat?ORKAMBI treats Cystic Fibrosis
What is Orkambi made of?ORKAMBI contains ivacaftor / lumacaftor which is a Cystic Fibrosis Transmembrane Conductance Regulator Potentiator
How Is Orkambi Administered?ORKAMBI is administered as a Oral Granules or Oral Pill
What Are The Orkambi Mechanism Of Action?ORKAMBI mechanism of action is Chloride Channel Activation Potentiators, Cytochrome P450 2B6 Inducers, Cytochrome P450 2C19 Inducers, Cytochrome P450 2C8 Inducers, Cytochrome P450 2C8 Inhibitors, Cytochrome P450 2C9 Inducers, Cytochrome P450 2C9 Inhibitors, Cytochrome P450 3A Inducers, Cytochrome P450 3A Inhibitors, Cytochrome P450 3A4 Inhibitors, P-Glycoprotein Inducers or P-Glycoprotein Inhibitors
FAQ Data Source
We receive information directly from the FDA and PrescriberPoint is updated as frequently as change are made available
